Categories: Health

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

 | Source: Chimerix, Inc.

DURHAM, N.C., Jan. 24, 2025 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), today announced that on January 17, 2025, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to six new employees of non-statutory stock options to purchase up to a total of 355,000 shares of Chimerix’s common stock. The Compensation Committee of Chimerix’s Board of Directors approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing rule 5635(c)(4).

The stock options have an exercise price per share equal to Chimerix’s closing trading price as of the grant date. The stock options have a 10-year term and will vest over four years, with one-fourth vesting on the one-year anniversary of the date of hire and the remaining three-fourths vesting over the following three years in equal monthly installments. The stock options are subject to the terms of Chimerix’s 2024 Equity Incentive Plan but were granted outside of the 2024 Equity Incentive Plan.

Chimerix is a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The Company’s most advanced clinical-stage development program, dordaviprone (ONC201), is in development for H3 K27M-mutant glioma. The Company is conducting Phase 1 dose escalation studies of ONC206 to evaluate safety and PK data.

CONTACTS:

Will O’Connor
Stern Investor Relations
212-362-1200
ir@chimerix.com
will@sternir.com

GlobeNews Wire

Recent Posts

Euro NCAP puts safety first for Europes 30 million van drivers

LEUVEN, BELGIUM – As the sales of new vans continue to increase across Europe and…

20 seconds ago

Hyundai Motor Group Delivers Enhanced InCar Experience Through Equinix Data Centers Globally

Connecting globally distributed data hubs on a secure, private infrastructure to accelerate seamless connected car…

21 seconds ago

Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

May 08, 2025 07:05 ET  | Source: Clearside Biomedical, Inc. ALPHARETTA, Ga., May 08, 2025…

58 minutes ago

Axogen, Inc. Reports 2025 First Quarter Financial Results

May 08, 2025 07:05 ET  | Source: Axogen, Inc. ALACHUA, Fla. and TAMPA, Fla., May…

58 minutes ago

Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative

Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX), a technology-first…

58 minutes ago

Invivyd to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025

May 08, 2025 07:01 ET  | Source: Invivyd WALTHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE)…

58 minutes ago